CA Stock MarketDetailed Quotes

XRTX XORTX Therapeutics Inc

Watchlist
  • 2.670
  • +0.480+21.92%
15min DelayMarket Closed Jul 12 16:00 ET
7.75MMarket Cap-1428P/E (TTM)

XORTX Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
-6,422.15%-967.56K
-163.88%-1.88M
Net income from continuing operations
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.57%-1.2M
-497.82%-1.24M
Operating gains losses
12,163.50%1.73M
-11.96%-3.66M
-312.04%-3.64M
100.27%2.16K
99.67%-4.58K
92.42%-14.36K
-25.17%-3.26M
90.55%-882.99K
-112.76%-792.44K
-170.53%-1.4M
Depreciation and amortization
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
557.56%22.06K
171.95%9.76K
Remuneration paid in stock
34.35%53.13K
-75.21%120.98K
-57.43%28.82K
13.40%21.85K
-90.76%30.77K
-41.90%39.55K
23.09%487.94K
-42.44%67.68K
-54.31%19.27K
338.92%332.91K
Other non cashItems
--224.49K
----
----
----
----
----
----
----
----
----
Change In working capital
56.14%-326.87K
-169.94%-1.03M
-70.44%-412.21K
-77.35%222.17K
-122.89%-95.51K
-334.66%-745.19K
236.03%1.47M
68.58%-241.84K
334.93%980.72K
715.62%417.32K
-Change in receivables
-34.20%29.83K
151.20%21.04K
140.47%7.53K
-129.02%-37.83K
108.73%6.01K
153.96%45.33K
-39.87%-41.1K
36.67%-18.61K
--130.36K
-196.92%-68.84K
-Change in prepaid assets
-442.78%-402.07K
-77.09%142.65K
52.92%-148.04K
-53.00%94.74K
-83.12%78.66K
-56.49%117.3K
178.34%622.6K
56.87%-314.46K
1,531.91%201.6K
1,002.75%465.87K
-Change in payables and accrued expense
105.00%45.37K
-233.87%-1.19M
-397.83%-271.7K
-74.53%165.25K
-988.26%-180.18K
-787.81%-907.82K
444.07%892.27K
908.34%91.23K
170.81%648.77K
123.26%20.28K
Cash from discontinued investing activities
Operating cash flow
47.54%-1.3M
26.56%-6.58M
64.08%-1.3M
-10.66%-1.07M
7.95%-1.73M
0.74%-2.49M
-86.70%-8.96M
-14.81%-3.61M
-6,422.15%-967.56K
-163.88%-1.88M
Investing cash flow
Cash flow from continuing investing activities
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
50.51%-4.66K
-160.36%-21.58K
Net PPE purchase and sale
--0
78.11%-4.31K
99.98%-1
--0
88.89%-1.64K
---2.67K
---19.7K
---5.42K
--458
---14.73K
Net intangibles purchas and sale
84.62%-2.62K
-61.71%-42.05K
14.02%-9.79K
-42.50%-7.3K
-15.31%-7.9K
-546.14%-17.06K
18.24%-26.01K
18.32%-11.39K
45.65%-5.12K
17.34%-6.85K
Cash from discontinued investing activities
Investing cash flow
86.71%-2.62K
-1.45%-46.36K
41.75%-9.8K
-56.50%-7.3K
55.81%-9.54K
-647.39%-19.73K
-43.68%-45.7K
-20.58%-16.82K
50.51%-4.66K
-160.36%-21.58K
Financing cash flow
Cash flow from continuing financing activities
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
-21.98K
-75.69%4.71M
-62.80%5.18M
-123.59%-460.78K
-107.55%-6.19K
Net issuance payments of debt
0.73%-15.95K
-223.81%-66.09K
-755.66%-17K
-36.34%-16.67K
-163.98%-16.35K
---16.06K
---20.41K
---1.99K
---12.23K
---6.19K
Net common stock issuance
--2M
--0
----
----
----
--0
-72.34%5M
----
----
----
Proceeds from stock option exercised by employees
5,497.97%16.57K
362.50%296
--0
--0
--0
--296
-100.00%64
-99.99%64
--0
--0
Net other financing activities
-4,692.38%-297.61K
-9.53%-295.25K
----
----
----
---6.21K
61.41%-269.56K
248.81%179K
----
----
Cash from discontinued financing activities
Financing cash flow
7,851.59%1.7M
-107.67%-361.04K
-106.03%-312.25K
96.38%-16.67K
-63.72%-10.14K
---21.98K
-75.69%4.71M
-62.80%5.18M
-123.59%-460.78K
-107.55%-6.19K
Net cash flow
Beginning cash position
-66.96%3.45M
-29.83%10.43M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
10,954.34%14.87M
126.44%8.87M
150.81%10.41M
159.24%12.41M
Current changes in cash
115.71%397.09K
-62.59%-6.99M
-204.79%-1.62M
23.61%-1.09M
8.26%-1.75M
-0.82%-2.53M
-129.57%-4.3M
-85.63%1.55M
-522.12%-1.43M
-198.75%-1.91M
Effect of exchange rate changes
-903.19%-9.32K
102.97%4.04K
-109.02%-1.45K
99.78%-246
105.02%4.58K
-97.60%1.16K
-169.51%-136.15K
-91.78%16.1K
---109.44K
---91.23K
End cash Position
-51.50%3.84M
-66.96%3.45M
-66.96%3.45M
-42.86%5.07M
-40.81%6.16M
-36.28%7.91M
-29.83%10.43M
-29.83%10.43M
126.44%8.87M
150.81%10.41M
Free cash from
47.84%-1.31M
26.41%-6.63M
63.98%-1.31M
-10.88%-1.08M
8.49%-1.74M
0.06%-2.5M
-86.42%-9.01M
-14.83%-3.63M
-3,907.55%-972.22K
-163.84%-1.9M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M-6,422.15%-967.56K-163.88%-1.88M
Net income from continuing operations -64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.57%-1.2M-497.82%-1.24M
Operating gains losses 12,163.50%1.73M-11.96%-3.66M-312.04%-3.64M100.27%2.16K99.67%-4.58K92.42%-14.36K-25.17%-3.26M90.55%-882.99K-112.76%-792.44K-170.53%-1.4M
Depreciation and amortization -51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K557.56%22.06K171.95%9.76K
Remuneration paid in stock 34.35%53.13K-75.21%120.98K-57.43%28.82K13.40%21.85K-90.76%30.77K-41.90%39.55K23.09%487.94K-42.44%67.68K-54.31%19.27K338.92%332.91K
Other non cashItems --224.49K------------------------------------
Change In working capital 56.14%-326.87K-169.94%-1.03M-70.44%-412.21K-77.35%222.17K-122.89%-95.51K-334.66%-745.19K236.03%1.47M68.58%-241.84K334.93%980.72K715.62%417.32K
-Change in receivables -34.20%29.83K151.20%21.04K140.47%7.53K-129.02%-37.83K108.73%6.01K153.96%45.33K-39.87%-41.1K36.67%-18.61K--130.36K-196.92%-68.84K
-Change in prepaid assets -442.78%-402.07K-77.09%142.65K52.92%-148.04K-53.00%94.74K-83.12%78.66K-56.49%117.3K178.34%622.6K56.87%-314.46K1,531.91%201.6K1,002.75%465.87K
-Change in payables and accrued expense 105.00%45.37K-233.87%-1.19M-397.83%-271.7K-74.53%165.25K-988.26%-180.18K-787.81%-907.82K444.07%892.27K908.34%91.23K170.81%648.77K123.26%20.28K
Cash from discontinued investing activities
Operating cash flow 47.54%-1.3M26.56%-6.58M64.08%-1.3M-10.66%-1.07M7.95%-1.73M0.74%-2.49M-86.70%-8.96M-14.81%-3.61M-6,422.15%-967.56K-163.88%-1.88M
Investing cash flow
Cash flow from continuing investing activities 86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K50.51%-4.66K-160.36%-21.58K
Net PPE purchase and sale --078.11%-4.31K99.98%-1--088.89%-1.64K---2.67K---19.7K---5.42K--458---14.73K
Net intangibles purchas and sale 84.62%-2.62K-61.71%-42.05K14.02%-9.79K-42.50%-7.3K-15.31%-7.9K-546.14%-17.06K18.24%-26.01K18.32%-11.39K45.65%-5.12K17.34%-6.85K
Cash from discontinued investing activities
Investing cash flow 86.71%-2.62K-1.45%-46.36K41.75%-9.8K-56.50%-7.3K55.81%-9.54K-647.39%-19.73K-43.68%-45.7K-20.58%-16.82K50.51%-4.66K-160.36%-21.58K
Financing cash flow
Cash flow from continuing financing activities 7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K-21.98K-75.69%4.71M-62.80%5.18M-123.59%-460.78K-107.55%-6.19K
Net issuance payments of debt 0.73%-15.95K-223.81%-66.09K-755.66%-17K-36.34%-16.67K-163.98%-16.35K---16.06K---20.41K---1.99K---12.23K---6.19K
Net common stock issuance --2M--0--------------0-72.34%5M------------
Proceeds from stock option exercised by employees 5,497.97%16.57K362.50%296--0--0--0--296-100.00%64-99.99%64--0--0
Net other financing activities -4,692.38%-297.61K-9.53%-295.25K---------------6.21K61.41%-269.56K248.81%179K--------
Cash from discontinued financing activities
Financing cash flow 7,851.59%1.7M-107.67%-361.04K-106.03%-312.25K96.38%-16.67K-63.72%-10.14K---21.98K-75.69%4.71M-62.80%5.18M-123.59%-460.78K-107.55%-6.19K
Net cash flow
Beginning cash position -66.96%3.45M-29.83%10.43M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M10,954.34%14.87M126.44%8.87M150.81%10.41M159.24%12.41M
Current changes in cash 115.71%397.09K-62.59%-6.99M-204.79%-1.62M23.61%-1.09M8.26%-1.75M-0.82%-2.53M-129.57%-4.3M-85.63%1.55M-522.12%-1.43M-198.75%-1.91M
Effect of exchange rate changes -903.19%-9.32K102.97%4.04K-109.02%-1.45K99.78%-246105.02%4.58K-97.60%1.16K-169.51%-136.15K-91.78%16.1K---109.44K---91.23K
End cash Position -51.50%3.84M-66.96%3.45M-66.96%3.45M-42.86%5.07M-40.81%6.16M-36.28%7.91M-29.83%10.43M-29.83%10.43M126.44%8.87M150.81%10.41M
Free cash from 47.84%-1.31M26.41%-6.63M63.98%-1.31M-10.88%-1.08M8.49%-1.74M0.06%-2.5M-86.42%-9.01M-14.83%-3.63M-3,907.55%-972.22K-163.84%-1.9M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg